全球連續血糖監測儀市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計持續血糖監測市場將從 2025 年的 156.3 億美元成長到 2034 年的 578.1 億美元，2026 年至 2034 年的複合年成長率為 15.64%。

受全球糖尿病患者人數不斷增加的推動，全球持續血糖監測市場正經歷快速成長。持續血糖監測系統可全天即時測量血糖值，為患者和醫療專業人員提供有關血糖值波動模式的重要資訊。這些設備有助於患者及時調整飲食、藥物和生活方式，進而改善糖尿病管理。

市場成長主要受全球糖尿病盛行率上升和對先進監測技術需求不斷成長的推動。與傳統血糖檢測法相比，連續血糖監測儀能夠提供更準確、更連續的數據。穿戴式感測器技術的進步以及與行動應用程式的整合，也提高了患者的便利性和監測效率。

隨著數位健康技術的不斷發展，持續血糖監測市場前景十分廣闊。與智慧胰島素輸注系統和行動醫療平台的整合，有望實現更個人化的糖尿病管理。此外，發展中國家糖尿病醫療意識的提高和醫療服務覆蓋範圍的擴大也將推動市場成長。隨著技術進步提升病患監測能力，持續血糖監測系統將在糖尿病治療中發揮至關重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球連續血糖監測儀市場：依組件分類

• 市場分析、洞察與預測
• 感應器
• 發送器
• 接收器

第5章：全球連續血糖監測儀市場：依年齡層別分類

• 市場分析、洞察與預測
• 成人
• 兒童

第6章 全球連續血糖監測儀市場：依最終用戶分類

• 市場分析、洞察與預測
• 居家醫療環境
• 醫院和診所

第7章 全球連續血糖監測儀市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • DexCom Inc
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Medironic. Plc
  • Nemaura Medical Inc
  • LifeScan Inc
  • Senseonics Holdings Inc.（US）
  • A Menarini Diagnostics Srl
  • Medtrum. Technologies Inc
  • B. Braun SE

The Continuous Glucose Monitoring Meter Market size is expected to reach USD 57.81 Billion in 2034 from USD 15.63 Billion (2025) growing at a CAGR of 15.64% during 2026-2034.

The global continuous glucose monitoring meter market has experienced rapid growth due to increasing cases of diabetes worldwide. Continuous glucose monitoring systems measure glucose levels in real time throughout the day, providing patients and healthcare providers with valuable insights into blood sugar patterns. These devices help improve diabetes management by allowing patients to make timely adjustments to diet, medication, and lifestyle.

Market growth is driven by the rising global prevalence of diabetes and the increasing demand for advanced monitoring technologies. Continuous glucose monitoring meters provide more accurate and continuous data compared to traditional blood glucose testing methods. The development of wearable sensors and mobile application connectivity has also improved patient convenience and monitoring efficiency.

The future of the continuous glucose monitoring meter market appears highly promising as digital health technologies continue to evolve. Integration with smart insulin delivery systems and mobile health platforms may enable more personalized diabetes management. Increasing healthcare awareness and expanding access to diabetes care in developing regions will also support market growth. As technology improves patient monitoring capabilities, continuous glucose monitoring systems will play a vital role in diabetes care.

MARKET SEGMENTATION

By Component

• Sensors
• Transmitters
• Receivers

By Age Group

• Adults
• Children

By End User

• Home Care Settings
• Hospitals and Clinics

COMPANIES PROFILED

• DexCom Inc, Abbott Laboratories, F HoffmannLa Roche Ltd, Medironic plc, Nemaura Medical Inc, LifeScan Inc, Senseonics Holdings Inc US, A Menarini Diagnostics Srl, Medtrum Technologies Inc, B Braun SE
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Sensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Transmitters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Receivers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Age Group
• 5.2. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Children Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Component
  • 7.2.2 By Age Group
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Component
  • 7.3.2 By Age Group
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Component
  • 7.4.2 By Age Group
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Component
  • 7.5.2 By Age Group
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Component
  • 7.6.2 By Age Group
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CONTINUOUS GLUCOSE MONITORING METER INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 DexCom Inc
  • 9.2.2 Abbott Laboratories
  • 9.2.3 F. Hoffmann-La Roche Ltd
  • 9.2.4 Medironic. Plc
  • 9.2.5 Nemaura Medical Inc
  • 9.2.6 LifeScan Inc
  • 9.2.7 Senseonics Holdings Inc. (US)
  • 9.2.8 A Menarini Diagnostics Srl
  • 9.2.9 Medtrum. Technologies Inc
  • 9.2.10 B. Braun SE